These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30725184)

  • 1. Intrafollicular melatonin concentration is elevated in patients with ovarian hyperstimulation syndrome (OHSS) and can serve as an important predictor of OHSS.
    Zheng M; Zuo G; Tong J; Chen ZJ; Li WP; Zhang C
    Arch Gynecol Obstet; 2019 Apr; 299(4):1151-1158. PubMed ID: 30725184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin concentration in follicular fluid is correlated with antral follicle count (AFC) and in vitro fertilization (IVF) outcomes in women undergoing assisted reproductive technology (ART) procedures.
    Zheng M; Tong J; Li WP; Chen ZJ; Zhang C
    Gynecol Endocrinol; 2018 May; 34(5):446-450. PubMed ID: 29185361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer.
    Ciepiela P; Dulęba AJ; Kario A; Chełstowski K; Branecka-Woźniak D; Kurzawa R
    Hum Reprod; 2019 Nov; 34(11):2244-2253. PubMed ID: 31725884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI.
    Sun B; Ma Y; Li L; Hu L; Wang F; Zhang Y; Dai S; Sun Y
    Front Endocrinol (Lausanne); 2020; 11():615957. PubMed ID: 33542709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Müllerian hormone levels to predict oocyte maturity and embryo quality during controlled ovarian hyperstimulation.
    Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
    Minerva Ginecol; 2017 Jun; 69(3):225-232. PubMed ID: 27352270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and follicular fluid (FF) estradiol (E2) levels in ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) and gamete intrafallopian transfer (GIFT) conception cycles after pituitary suppression.
    Leya J; Molo MW; Olson D; Radwanska E
    J In Vitro Fert Embryo Transf; 1991 Jun; 8(3):137-40. PubMed ID: 1919258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
    von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
    Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of follicular fluid and serum levels of Inhibin A and Inhibin B with calculated indices used as predictive markers of Ovarian Hyperstimulation Syndrome in IVF patients.
    Moos J; Rezabek K; Filova V; Moosova M; Pavelkova J; Peknicova J
    Reprod Biol Endocrinol; 2009 Aug; 7():86. PubMed ID: 19703287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.
    Tsakos E; Tolikas A; Daniilidis A; Asimakopoulos B
    Arch Gynecol Obstet; 2014 Dec; 290(6):1249-53. PubMed ID: 25001569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antagonist mild and long agonist protocols in terms of follicular fluid total antioxidant capacity.
    Aydogan Mathyk B; Aslan Cetin B; Vardagli D; Zengin E; Sofiyeva N; Irez T; Ocal P
    Taiwan J Obstet Gynecol; 2018 Apr; 57(2):194-199. PubMed ID: 29673660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.
    Ocal P; Sahmay S; Cetin M; Irez T; Guralp O; Cepni I
    J Assist Reprod Genet; 2011 Dec; 28(12):1197-203. PubMed ID: 21882017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of follicular fluid phthalate metabolites on the ovarian reserve and ovarian function in Indian women undergoing intracytoplasmic sperm injection.
    Parikh FR; Uttamchandani S; Sawkar S; Panpalia M; Naik N; Sinkar P; Kulkarni D; Parikh R
    F S Sci; 2024 May; 5(2):107-120. PubMed ID: 38219085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relations between steroids and AMH: impact of basal and intrafollicular steroids to AMH ratios on oocyte yield and maturation rate in women with or without polycystic ovary undergoing in vitro fertilization.
    Hossein G; Arabzadeh S; Hossein-Rashidi B; Hosseini MA
    Gynecol Endocrinol; 2012 Jun; 28(6):413-7. PubMed ID: 21992510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
    Anaya Y; Mata DA; Letourneau J; Cakmak H; Cedars MI; Rosen MP
    J Assist Reprod Genet; 2018 Feb; 35(2):297-307. PubMed ID: 29086322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Smoothing Gan Reinforcing Shen Method Adjuvantly Treated Poor Response of Diminished Ovari- an Reserve Patients in in vitro Fertilization and Embryo Transfer: a Clinical Study].
    Zhang Z; Zhang XH; He TY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Oct; 35(10):1170-4. PubMed ID: 26677665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the outcome of different protocols of in vitro fertilization with anti-Muüllerian hormone levels in patients with polycystic ovary syndrome.
    Chen Y; Ye B; Yang X; Zheng J; Lin J; Zhao J
    J Int Med Res; 2017 Jun; 45(3):1138-1147. PubMed ID: 28449632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-free nucleic acids and melatonin levels in human follicular fluid predict embryo quality in patients undergoing in-vitro fertilization treatment.
    Latif Khan H; Bhatti S; Latif Khan Y; Abbas S; Munir Z; Rahman Khan Sherwani IA; Suhail S; Hassan Z; Aydin HH
    J Gynecol Obstet Hum Reprod; 2020 Jan; 49(1):101624. PubMed ID: 31472269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
    Majumder K; Gelbaya TA; Laing I; Nardo LG
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles.
    Lee TH; Liu CH; Huang CC; Wu YL; Shih YT; Ho HN; Yang YS; Lee MS
    Hum Reprod; 2008 Jan; 23(1):160-7. PubMed ID: 18000172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization.
    Lee A; Christenson LK; Stouffer RL; Burry KA; Patton PE
    Fertil Steril; 1997 Aug; 68(2):305-11. PubMed ID: 9240261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.